Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Central nervous system has a profound role in regulation of gastric mucosal integrity. Different neuropeptides such as peptide YY, amylin, leptin, ghrelin, opioids (e.g. β-endorphin, deltorphin II, endomorphins), nociceptin, nocistatin, TLQP-21 and substance P were shown to protect the gastric mucosa in experimental ulcer models given centrally. Most of the neuropeptides induced gastroprotective action in pmolar dose range injected intracerebroventricularly (i.c.v.) or intracisternally (i.c.), endomorphins and β-endorphin, proved to be effective even in femtomoles. Dorsal vagal complex and vagal efferents have basic role in conveying the centrally initiated effect to the periphery. However, the potential role of sympathetic nervous system in centrally-induced mucosal protection has also been raised. Our previous results showed that the gastroprotective effect of opioid peptides was reduced significantly but not abolished by bilateral vagotomy. Now it was demonstrated that the protective effect of [D-Ala (2), D-Leu (5)]-ol-enkephalin (DAGO; 38 pmol), β-endorphin (10 pmol) and endomorphin-2 (0.1 pmol) injected i.c.v. was highly reduced after chemical sympathectomy by 6-OH dopamine (600 nmol i.c.v.). Simultaneously, the noradrenaline content of nucleus tractus solitarii (NTS) decreased from 1,881 ± 89 to 1,439 ± 154 pg/mg tissue (p<0.05) in 6-OH dopaminetreated rats. The results indicate that the integrity of the adrenergic system besides the cholinergic one may also be necessary for the centrally induced gastroprotection. Further research is needed to reveal the role of sympathetic nervous system as well as the interactions between neuropeptides in maintaining gastric mucosal integrity and gastric mucosal defense.

Original languageEnglish
Title of host publicationCell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment
PublisherS. Karger AG
Pages161-169
Number of pages9
Volume30
ISBN (Print)9783318021844, 9783318021837
DOIs
Publication statusPublished - Jun 22 2012

Fingerprint

Endorphins
Neurology
Neuropeptides
Stomach
Sympathetic Nervous System
Leucine-2-Alanine Enkephalin
Chemical Sympathectomy
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Peptide YY
Islet Amyloid Polypeptide
Ghrelin
Solitary Nucleus
Opioid Peptides
Enkephalins
Vagotomy
Conveying
Substance P
Leptin
Gastric Mucosa
Adrenergic Agents

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Gyires, K. (2012). Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally. In Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment (Vol. 30, pp. 161-169). S. Karger AG. https://doi.org/10.1159/000338428

Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally. / Gyires, K.

Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Vol. 30 S. Karger AG, 2012. p. 161-169.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gyires, K 2012, Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally. in Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. vol. 30, S. Karger AG, pp. 161-169. https://doi.org/10.1159/000338428
Gyires K. Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally. In Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Vol. 30. S. Karger AG. 2012. p. 161-169 https://doi.org/10.1159/000338428
Gyires, K. / Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally. Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment. Vol. 30 S. Karger AG, 2012. pp. 161-169
@inbook{ed5cc3f555974832beb25f39be4832f3,
title = "Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally",
abstract = "Central nervous system has a profound role in regulation of gastric mucosal integrity. Different neuropeptides such as peptide YY, amylin, leptin, ghrelin, opioids (e.g. β-endorphin, deltorphin II, endomorphins), nociceptin, nocistatin, TLQP-21 and substance P were shown to protect the gastric mucosa in experimental ulcer models given centrally. Most of the neuropeptides induced gastroprotective action in pmolar dose range injected intracerebroventricularly (i.c.v.) or intracisternally (i.c.), endomorphins and β-endorphin, proved to be effective even in femtomoles. Dorsal vagal complex and vagal efferents have basic role in conveying the centrally initiated effect to the periphery. However, the potential role of sympathetic nervous system in centrally-induced mucosal protection has also been raised. Our previous results showed that the gastroprotective effect of opioid peptides was reduced significantly but not abolished by bilateral vagotomy. Now it was demonstrated that the protective effect of [D-Ala (2), D-Leu (5)]-ol-enkephalin (DAGO; 38 pmol), β-endorphin (10 pmol) and endomorphin-2 (0.1 pmol) injected i.c.v. was highly reduced after chemical sympathectomy by 6-OH dopamine (600 nmol i.c.v.). Simultaneously, the noradrenaline content of nucleus tractus solitarii (NTS) decreased from 1,881 ± 89 to 1,439 ± 154 pg/mg tissue (p<0.05) in 6-OH dopaminetreated rats. The results indicate that the integrity of the adrenergic system besides the cholinergic one may also be necessary for the centrally induced gastroprotection. Further research is needed to reveal the role of sympathetic nervous system as well as the interactions between neuropeptides in maintaining gastric mucosal integrity and gastric mucosal defense.",
author = "K. Gyires",
year = "2012",
month = "6",
day = "22",
doi = "10.1159/000338428",
language = "English",
isbn = "9783318021844",
volume = "30",
pages = "161--169",
booktitle = "Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment",
publisher = "S. Karger AG",

}

TY - CHAP

T1 - Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally

AU - Gyires, K.

PY - 2012/6/22

Y1 - 2012/6/22

N2 - Central nervous system has a profound role in regulation of gastric mucosal integrity. Different neuropeptides such as peptide YY, amylin, leptin, ghrelin, opioids (e.g. β-endorphin, deltorphin II, endomorphins), nociceptin, nocistatin, TLQP-21 and substance P were shown to protect the gastric mucosa in experimental ulcer models given centrally. Most of the neuropeptides induced gastroprotective action in pmolar dose range injected intracerebroventricularly (i.c.v.) or intracisternally (i.c.), endomorphins and β-endorphin, proved to be effective even in femtomoles. Dorsal vagal complex and vagal efferents have basic role in conveying the centrally initiated effect to the periphery. However, the potential role of sympathetic nervous system in centrally-induced mucosal protection has also been raised. Our previous results showed that the gastroprotective effect of opioid peptides was reduced significantly but not abolished by bilateral vagotomy. Now it was demonstrated that the protective effect of [D-Ala (2), D-Leu (5)]-ol-enkephalin (DAGO; 38 pmol), β-endorphin (10 pmol) and endomorphin-2 (0.1 pmol) injected i.c.v. was highly reduced after chemical sympathectomy by 6-OH dopamine (600 nmol i.c.v.). Simultaneously, the noradrenaline content of nucleus tractus solitarii (NTS) decreased from 1,881 ± 89 to 1,439 ± 154 pg/mg tissue (p<0.05) in 6-OH dopaminetreated rats. The results indicate that the integrity of the adrenergic system besides the cholinergic one may also be necessary for the centrally induced gastroprotection. Further research is needed to reveal the role of sympathetic nervous system as well as the interactions between neuropeptides in maintaining gastric mucosal integrity and gastric mucosal defense.

AB - Central nervous system has a profound role in regulation of gastric mucosal integrity. Different neuropeptides such as peptide YY, amylin, leptin, ghrelin, opioids (e.g. β-endorphin, deltorphin II, endomorphins), nociceptin, nocistatin, TLQP-21 and substance P were shown to protect the gastric mucosa in experimental ulcer models given centrally. Most of the neuropeptides induced gastroprotective action in pmolar dose range injected intracerebroventricularly (i.c.v.) or intracisternally (i.c.), endomorphins and β-endorphin, proved to be effective even in femtomoles. Dorsal vagal complex and vagal efferents have basic role in conveying the centrally initiated effect to the periphery. However, the potential role of sympathetic nervous system in centrally-induced mucosal protection has also been raised. Our previous results showed that the gastroprotective effect of opioid peptides was reduced significantly but not abolished by bilateral vagotomy. Now it was demonstrated that the protective effect of [D-Ala (2), D-Leu (5)]-ol-enkephalin (DAGO; 38 pmol), β-endorphin (10 pmol) and endomorphin-2 (0.1 pmol) injected i.c.v. was highly reduced after chemical sympathectomy by 6-OH dopamine (600 nmol i.c.v.). Simultaneously, the noradrenaline content of nucleus tractus solitarii (NTS) decreased from 1,881 ± 89 to 1,439 ± 154 pg/mg tissue (p<0.05) in 6-OH dopaminetreated rats. The results indicate that the integrity of the adrenergic system besides the cholinergic one may also be necessary for the centrally induced gastroprotection. Further research is needed to reveal the role of sympathetic nervous system as well as the interactions between neuropeptides in maintaining gastric mucosal integrity and gastric mucosal defense.

UR - http://www.scopus.com/inward/record.url?scp=84925853656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925853656&partnerID=8YFLogxK

U2 - 10.1159/000338428

DO - 10.1159/000338428

M3 - Chapter

SN - 9783318021844

SN - 9783318021837

VL - 30

SP - 161

EP - 169

BT - Cell/Tissue Injury and Cytoprotection/Organoprotection in the Gastrointestinal Tract: Mechanisms, Prevention and Treatment

PB - S. Karger AG

ER -